242 related articles for article (PubMed ID: 31683483)
41. Comparison between a Paper-Pencil Version and Computerized Version for the Realization of a Neuropsychological Test: The Example of the Trail Making Test.
Sacco G; Ben-Sadoun G; Bourgeois J; Fabre R; Manera V; Robert P
J Alzheimers Dis; 2019; 68(4):1657-1666. PubMed ID: 30909209
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S
EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590
[TBL] [Abstract][Full Text] [Related]
43. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
Zainal NH; Silva E; Lim LL; Kandiah N
Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
[TBL] [Abstract][Full Text] [Related]
44. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
[TBL] [Abstract][Full Text] [Related]
45. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
[TBL] [Abstract][Full Text] [Related]
46. Tai Chi Improves Cognition and Plasma BDNF in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial.
Sungkarat S; Boripuntakul S; Kumfu S; Lord SR; Chattipakorn N
Neurorehabil Neural Repair; 2018 Feb; 32(2):142-149. PubMed ID: 29353543
[TBL] [Abstract][Full Text] [Related]
47. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
[TBL] [Abstract][Full Text] [Related]
48. Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial.
Xing D; Yoo C; Gonzalez D; Jenkins V; Nottingham K; Dickerson B; Leonard M; Ko J; Faries M; Kephart W; Purpura M; Jäger R; Wells SD; Sowinski R; Rasmussen CJ; Kreider RB
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960030
[TBL] [Abstract][Full Text] [Related]
49. MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case-control study.
Yu Y; Zhao W; Li S; Yin C
BMJ Open; 2017 Mar; 7(3):e013432. PubMed ID: 28274963
[TBL] [Abstract][Full Text] [Related]
50. Effects of Chlorogenic Acid-Enriched and Hydroxyhydroquinone-Reduced Coffee on Postprandial Fat Oxidation and Antioxidative Capacity in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Katada S; Watanabe T; Mizuno T; Kobayashi S; Takeshita M; Osaki N; Kobayashi S; Katsuragi Y
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690626
[TBL] [Abstract][Full Text] [Related]
51. [Impact of dysexecutive syndrome on autonomy in early Alzheimer's disease and Mild cognitive impairment].
Jacus JP; Gély-Nargeot MC
Geriatr Psychol Neuropsychiatr Vieil; 2014 Mar; 12(1):101-12. PubMed ID: 24647244
[TBL] [Abstract][Full Text] [Related]
52. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
[TBL] [Abstract][Full Text] [Related]
53. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.
Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H
J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744
[TBL] [Abstract][Full Text] [Related]
54. Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease.
Tangen GG; Engedal K; Bergland A; Moger TA; Hansson O; Mengshoel AM
Int Psychogeriatr; 2015 Aug; 27(8):1401-9. PubMed ID: 25644091
[TBL] [Abstract][Full Text] [Related]
55. Timed Up and Go test, atrophy of medial temporal areas and cognitive functions in community-dwelling older adults with normal cognition and mild cognitive impairment.
Kose Y; Ikenaga M; Yamada Y; Morimura K; Takeda N; Ouma S; Tsuboi Y; Yamada T; Kimura M; Kiyonaga A; Higaki Y; Tanaka H;
Exp Gerontol; 2016 Dec; 85():81-87. PubMed ID: 27693131
[TBL] [Abstract][Full Text] [Related]
56. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
Buschert VC; Friese U; Teipel SJ; Schneider P; Merensky W; Rujescu D; Möller HJ; Hampel H; Buerger K
J Alzheimers Dis; 2011; 25(4):679-94. PubMed ID: 21483095
[TBL] [Abstract][Full Text] [Related]
57. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
58. Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition?: a cluster randomized controlled trial.
Lam LC; Chan WC; Leung T; Fung AW; Leung EM
PLoS One; 2015; 10(3):e0118173. PubMed ID: 25826620
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
Fioravanti M; Flicker L
Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
[TBL] [Abstract][Full Text] [Related]
60. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
